October 23, 2018
23RD OCTOBER 2018 EB8018, the lead investigational candidate, targets Crohn’s disease with potential for other GI disorders Paris, France and Cambridge, MA, USA – October 23, 2018 ENTEROME SA, a clinical-stage biotech company developing innovative therapies to treat microbiome-associated diseases with a focus on auto-immune disease and cancer, has entered into a global licensing, co-development and co-promotion...
Palma, Spain and San Diego, USA, 23 October, 2018 – Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, today announces that data from a phase I study assessing the safety and tolerability of its lead drug candidate SNF472 in haemodialysis patients has been published in the British Journal of Clinical...
Through their work on the brains of ants, a team of researchers at the University of Copenhagen has identified fundamental DNA networks which, with all likelihood, control brain activity. The discovery was recently published in the scientific journal Nature Ecology and Evolution. The method can be used to explore correlations between general brain functions and...


Your willingness to take risks is written in your genes
15. January 2019
New application programme open for experienced researchers
14. January 2019
Transparent mice map the brain’s washing machine
4. January 2019


Lundbeckfonden Ventures

Lundbeckfonden Emerge